Filing date Form Description Filing Group Issuer View
8-K

Report of unscheduled material events or corporate event

Current Reports
Crinetics Pharmaceuticals, Inc. EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
Crinetics Pharmaceuticals, Inc. EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
Crinetics Pharmaceuticals, Inc. EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
Crinetics Pharmaceuticals, Inc. View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
Crinetics Pharmaceuticals, Inc. View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
Crinetics Pharmaceuticals, Inc. View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
Crinetics Pharmaceuticals, Inc. View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
Crinetics Pharmaceuticals, Inc. View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
Crinetics Pharmaceuticals, Inc. EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
Crinetics Pharmaceuticals, Inc. View HTML

Data provided by Kaleidoscope.

Contact


Material Selections
Country

Contact


Material Selections
Country